Communiqués Venus Concept Inc.

Actions

VERO

US92332W2044

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
0,6 ^USD	-1,64 %		-1,64 %	-49,15 %

17/06	Venus Concept annonce un accord d'approvisionnement stratégique exclusif avec Skin Laundry	CI
12/06	Un initié de Venus Concept a vendu des actions d'une valeur de 589 868 $, selon un récent dépôt auprès de la SEC	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Venus Concept to Release Second Quarter of Fiscal Year 2024 Financial Results on August 13, 2024	15/07	AQ
Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America	27/06	AQ
Venus Concept Announces Exclusive Strategic Supply Arrangement with Skin Laundry	17/06	AQ
Venus Concept Regains Compliance with Nasdaq’s Minimum Equity Requirement	06/06	AQ
Venus Concept Announces Approval for Venus Versa Pro in Canada	03/06	AQ
Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction	28/05	AQ
Venus Concept: Q1 Earnings Snapshot	15/05	AQ
Venus Concept Announces First Quarter of Fiscal Year 2024 Financial Results	15/05	AQ
Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing	24/04	AQ
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024	15/04	AQ
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX	08/04	AQ
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro	03/04	AQ
Venus Concept: Q4 Earnings Snapshot	01/04	AQ
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results	01/04	AQ
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules	25/03	AQ
Venus Concept Launches “NEXThetics” Program	12/03	AQ
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB	28/02	AQ
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28/02	AQ
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	27/02	AQ
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI	27/02	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Venus Concept Inc.

Actions

VERO

US92332W2044

Communiqués

Filtres